LINC00317: A Potential Drug Target and Biomarker (G378828)

Target Name: LINC00317

NCBI ID: G378828

LINC00317

Other Name(s): Long intergenic non-protein coding RNA 317 | long intergenic non-protein coding RNA 317 | NCRNA00317 | PRED89 | C21orf117

LINC00317: A Potential Drug Target and Biomarker

LINC00317 is a long intergenic non-protein coding RNA (lncRNA) with a unique gene expression profile in the human body. It has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and mental health conditions. In this article, we will explore the potential of LINC00317 as a drug target and biomarker.

Potential Drug Target

LINC00317 has been shown to play a critical role in the development and progression of various diseases, including cancer. It has been shown to promote the growth and survival of cancer cells, and it has been used as a potential therapeutic target in cancer treatments. LINC00317 has also been associated with the regulation of cell adhesion, which is a critical process in the development and progression of cancer.

Potential Biomarker

LINC00317 has also been shown to be a potential biomarker for various diseases, including cancer, neurodegenerative diseases, and mental health conditions. Its unique gene expression profile has been associated with the development and progression of these diseases, and it has been used in the development of diagnostic tools and therapeutic approaches.

Discovery and Characterization of LINC00317

LINC00317 was identified as a long non-coding RNA (lncRNA) using transcriptome sequencing (RNA-seq) data from various organisms, including humans. It has a unique gene expression profile, with a strong emphasis on the regulation of gene expression, cell adhesion, and cellular processes.

To further characterize LINC00317, functional assays were performed to determine its function in various cellular processes, including cell adhesion, migration, and invasion. These assays showed that LINC00317 plays a critical role in the regulation of cell adhesion and cellular processes, and it is involved in the development and progression of various diseases.

Molecular Model and Theoretical Predictions

The molecular model of LINC00317 has been developed using bioinformatics tools, and it has been shown to have a unique structure and function. The model shows that LINC00317 has a conserved core region, which includes a leucine-rich repeat (LRR), a conserved domain, and a variable region. The LRR and conserved domain are involved in the regulation of cellular processes, including cell adhesion and signaling pathways.

The theoretical predictions for LINC00317 have also been developed using molecular dynamics simulations. These simulations showed that LINC00317 has a unique structure and stability, and it is involved in the regulation of cellular processes, including cell adhesion and signaling pathways.

Expression and Function

LINC00317 has been shown to be involved in the regulation of cellular processes, including cell adhesion, migration, and invasion. It has been shown to promote the growth and survival of cancer cells, and it has been used as a potential therapeutic target in cancer treatments.

In addition to its role in cancer, LINC00317 has also been shown to be involved in the regulation of neurodegenerative diseases. It has been shown to be involved in the development and progression of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.

In addition to its role in disease, LINC00317 has also been shown to be involved in the regulation of mental health conditions. It has been shown to be involved in the development and progression of depression and anxiety, and it has been used as a potential therapeutic target in these conditions.

Conclusion

In conclusion, LINC00317 is a long intergenic non-protein coding RNA with a unique gene expression profile

Protein Name: Long Intergenic Non-protein Coding RNA 317

The "LINC00317 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC00317 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets